Bastion Asset Management’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.11M Buy
79,452
+23,989
+43% +$2.03M 1.73% 21
2026
Q1
$6.1M Sell
55,463
-2,133
-4% -$278K 1.86% 24
2025
Q4
$7.23M Buy
57,596
+12,709
+28% +$1.59M 3.99% 12
2025
Q3
$5.13M Buy
+44,887
New +$5.25M 2.95% 11
2025
Q2
Sell
-4,740
Closed -$330K 78
2025
Q1
$330K Sell
4,740
-33,596
-88% -$2.31M 0.18% 51
2024
Q4
$2.4M Buy
+38,336
New +$3.57M 1.59% 27

Other funds holding TMDX

Bastion Asset Management's TMDX Position: Q2 2026 in Review

Bastion Asset Management increased its Transmedics (TMDX) stake by 43% in Q2 2026, buying an estimated $2.03M and bringing the position to 79,452 shares worth $5.11M. The position accounts for 1.73% of the portfolio, ranked #21.

Bastion Asset Management first reported a position in TMDX in Q4 2024 and has held it in 6 quarters since. The position peaked at $7.23M in Q4 2025. 374 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Bastion Asset Management held 79,452 shares of Transmedics worth $5.11M as of Q2 2026.
  • Bastion Asset Management bought 23,989 Transmedics shares in Q2 2026, an estimated $2.03M.
  • Transmedics made up 1.73% of Bastion Asset Management's portfolio in Q2 2026, its #21 holding.
  • Bastion Asset Management first reported a position in Transmedics in Q4 2024 and has held it in 6 quarters since.
  • Bastion Asset Management's Transmedics position peaked at $7.23M in Q4 2025.
  • 374 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Bastion Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.